| http://purl.uniprot.org/citations/34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/34345220 | http://www.w3.org/2000/01/rdf-schema#comment | "Patients suffering from breast cancer (BC) still have a poor response to treatments, even though early detection and improved therapy have contributed to a reduced mortality. Recent studies have been inspired on the association between microRNAs (miRs) and therapies of BC. The current study set out to investigate the role of miR-216b in BC, and further analyze the underlining mechanism. Firstly, hexokinase 2 (HK2) and miR-216b were characterized in BC tissues and cells by RT-qPCR and Western blot assay. In addition, the interaction between HK2 and miR-216b was analyzed using dual luciferase reporter assay. BC cells were further transfected with a series of miR-126b mimic or inhibitor, or siRNA targeting HK2, so as to analyze the regulatory mechanism of miR-216b, HK2 and mammalian target of rapamycin (mTOR) signaling pathway, and to further explore their regulation in BC cellular behaviors. The results demonstrated that HK2 was highly expressed and miR-216b was poorly expressed in BC cells and tissues. HK2 was also verified as a target of miR-216b with online databases and dual luciferase reporter assay. Functionally, miR-216b was found to be closely associated with BC progression via inactivating mTOR signaling pathway by targeting HK2. Moreover, cell viability, migration and invasion were reduced as a result of miR-216b upregulation or HK2 silencing, while autophagy, cell cycle arrest and apoptosis were induced. Taken together, our findings indicated that miR-216 down-regulates HK2 to inactivate the mTOR signaling pathway, thus inhibiting the progression of BC. Hence, this study highlighted a novel target for BC treatment."xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.org/dc/terms/identifier | "doi:10.7150/ijbs.48933"xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/author | "Han B."xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/author | "Liu T."xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/author | "Ye Y."xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/author | "Ye P."xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/date | "2021"xsd:gYear |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/name | "Int J Biol Sci"xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/pages | "2970-2983"xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/title | "MicroRNA-216b targets HK2 to potentiate autophagy and apoptosis of breast cancer cells via the mTOR signaling pathway."xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://purl.uniprot.org/core/volume | "17"xsd:string |
| http://purl.uniprot.org/citations/34345220 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/34345220 |
| http://purl.uniprot.org/citations/34345220 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/34345220 |
| http://purl.uniprot.org/uniprot/#_P52789-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_A8K2U2-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_A0A8V8TQ52-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_B4DZD5-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_B3KX59-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_B4E2H2-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_P42345-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_Q53QX9-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_Q53SG7-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_Q09LL6-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |
| http://purl.uniprot.org/uniprot/#_Q68E10-mappedCitation-34345220 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/34345220 |